NRX Pharmaceuticals (NRXP) Interest Coverage Ratio (2017 - 2026)

NRX Pharmaceuticals (NRXP) posted quarterly Interest Coverage Ratio of 20.35 for Q1 2026, down 30.72% quarter-over-quarter from 15.57 in Q4 2025.

NRX Pharmaceuticals (NRXP) Interest Coverage Ratio (2017 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has reported Interest Coverage Ratio for 8 consecutive years, with 20.35 the latest figure, recorded in Q1 2026.

In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 20.35; the TTM figure through Mar 2026 stood at 32.3 (up 54.56% YoY), while the FY2025 annual figure was 0.32, up 14.94% from the prior year.
Interest Coverage Ratio slipped to 20.35 in Q1 2026 per NRXP's latest filing, from 15.57 in the prior quarter.
Across five years, Interest Coverage Ratio topped out at 16.89 in Q4 2024 and bottomed at 178.0 in Q2 2023.
Historically, Interest Coverage Ratio has averaged 31.41 across 5 years, with a median of 20.35 in 2026.
Annual changes were most pronounced in 2022 — Interest Coverage Ratio plunged 6526.46% — and 2024, when it surged 170.91%.
NRX Pharmaceuticals' Interest Coverage Ratio stood at 3.88 in 2022, then tumbled by 513.95% to 23.82 in 2023, then soared by 170.91% to 16.89 in 2024, then slumped by 192.19% to 15.57 in 2025, then sank by 30.72% to 20.35 in 2026.
Business Quant data shows NRXP's Interest Coverage Ratio at 20.35 in Q1 2026, 15.57 in Q4 2025, and 21.29 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	117.59
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	2.82
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.86
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-0.08
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	1.42
10	NRX Pharmaceuticals	132.53 Mn	105.83 Mn	426,000.00	-27.10

Download Data